Would you recommend imatinib 400 mg BID or stay with the usual dose of 400 mg/day for adjuvant therapy for a patient with intermediate-high risk exon 9 mutated GIST?  

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at Alvin & Lois Lapidus Cancer Institute Northwest Hospital
How do you approach the adjuvant treatment of an e...
Sign in or Register to read more